The Indiana University School of Medicine (IUSM) and the Indiana University Precision Health Initiative (PHI) seeks to recruit faculty with a research program focused in a Pediatric Cancer. Precision Health Initiative was created with the bold goal of addressing major and large-scale health problems facing humanity through multidisciplinary teams of outstanding, innovative researchers. Precision Health was selected as the first recipient of funding from Indiana University Grand Challenges Program that is a $300 million research expansion across the entire University. The $120 million investment in Precision Health will be leveraged to recruit approximately 40 new, full-time faculty members on the Indiana University campuses in Bloomington and Indianapolis. Precision Health has supported the creation of new facilities, centers, and user platforms, including new gene editing and sequencing cores at the IUSM, and a Good Manufacturing Practice Cell Therapy (GMP) facility to produce cellular therapeutics. This investment will be leveraged with other IUSM resources to significant expand the scope of this initiative. Genomic Medicine is one of the specific areas that will be supported with substantial resources to build programs. This is an opportunity to create a vision for research and clinical implementation of genomic medicine across one of the largest health systems in the nation.
Innovation and research in the area of myeloid leukemias (acute myeloid leukemia, mixed lineage leukemia, juvenile myelomonocytic leukemia, and myelodysplastic syndromes), hematopoietic stem cell transplantation (stem cell biology, immunology, and biomarkers), and RASopathies are a major focus at IUSM. The Department of Pediatrics is ranked eighth nationally in NIH funding (JAMA Pediatrics 2018). IUSM scientists lead the NIH-funded: The Hematopoietic stem and progenitor cell regulation for enhanced clinical efficacy U54 which supports clinical and basic science research; The Developmental and HyperActive Ras Tumor (DHART) SPORE program that deploys approaches to address the fundamental problem of how to accelerate new therapies for uncommon (
Internal Number: 6711
About Indiana University
Founded in 1820, Indiana University is the state’s public university system, comprised of two core campuses—IU-Bloomington and IUPUI—and six regional campuses located throughout the state. Combined, the total student population is more than 114,000 undergraduate, graduate and professional school students. IU is one of the largest employers in the state, with over 20,000 faculty and staff. Indiana University is an equal employment and affirmative action employer and a provider of ADA services. Diversity and inclusion remains a core commitment to IU’s mission to cultivate an educational environment that supports equal access, participation and representation on all of its campuses and that provides educational and career opportunities for all.